A brand-new kind of drug, tested in mice, shows promising new results that could lead to the development of a new weight-loss drug that mimics exercise.
In summary, the ERR agonist SLU-PP-332 functions as an exercise mimetic inducing an
acute aerobic exercise program that leads to myriad physiological adaptations that are
associated with exercise including increased skeletal muscle oxidative fibers, increased fatty
acid oxidation, and enhanced exercise endurance
Gainz